MoonLake Immunotherapeutics appoints chairman and director
Simon Sturge has 40 years of international leadership experience in the biotechnology and pharmaceutical industry.
Most recently, he was Chief Executive Officer of Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immunologic disease and immune-oncology, and was instrumental in its sale to Sanofi in early 2021.
Previously, Mr. Sturge served as Chief Operating Officer for Merck Healthcare, a division of Merck KGaA.
He has also held roles at Boehringer Ingelheim, Celltech Biologics and Ribotargets.
MoonLake also announced that Spike Loy, Managing Director of BVF Partners L.P. ("BVF") has been appointed a Member of the Board of Directors.
Mr. Loy has been a member of BVF's investment team since 2009. ■